Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04494906
Other study ID # YM109104F
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 19, 2020
Est. completion date December 31, 2021

Study information

Verified date August 2020
Source National Yang Ming University
Contact Yea-Ru Yang, PhD
Phone +886-2-28267279
Email yryang@ym.edu.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to investigate the effects of interactive stepping exercise on balance and cognitive function in individuals with PD.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 31, 2021
Est. primary completion date December 31, 2021
Accepts healthy volunteers No
Gender All
Age group 50 Years to 85 Years
Eligibility Inclusion Criteria:

- Idiopathic PD

- Hoehn & Yahr stage between 1 to 3

- Age between 50 to 85

- Stable pharmacologic treatment for the last 2 weeks

- Ability to walk 10 meters unassisted or with assistive devices

Exclusion Criteria:

- Other neurological disorders diagnosis than PD

- Receiving any neurological surgeries

- Any musculoskeletal disorder or cardiopulmonary disease that may influence participation in the study

- The Mini-Mental State Examination (MMSE) < 24 scores

- Participated in other exercise intervention of study in the past 3 months

- Colorblindness or color vision deficiency

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Interactive stepping exercise
An exercise intervention based on the principle of square stepping exercise
Square stepping exercise
Square stepping exercise

Locations

Country Name City State
Taiwan National Yang-Ming University Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Yang Ming University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Romberg test To evaluate static balance ability Change from baseline at 8 weeks and 12 weeks
Primary Sharpened Romberg test To evaluate static balance ability Change from baseline at 8 weeks and 12 weeks
Primary One-leg stance test To evaluate static balance ability Change from baseline at 8 weeks and 12 weeks
Primary Timed up and go test To evaluate functional walking ability Change from baseline at 8 weeks and 12 weeks
Primary Mini-Balance Evaluation Systems Test To evaluate balance ability Change from baseline at 8 weeks and 12 weeks
Primary Montreal Cognitive Assessment Chinese version To evaluate global cognitive function Change from baseline at 8 weeks and 12 weeks
Primary Digit span test To evaluate executive function Change from baseline at 8 weeks and 12 weeks
Primary Stroop color and word test Chinese version To evaluate executive function Change from baseline at 8 weeks and 12 weeks
Primary Trail-making test Chinese version To evaluate executive function Change from baseline at 8 weeks and 12 weeks
Primary Spatial span test To evaluate visuospatial ability Change from baseline at 8 weeks and 12 weeks
Secondary 10-meter walk test To evaluate walking ability Change from baseline at 8 weeks and 12 weeks
Secondary Parkinson's Disease Questionnaire 39 To evaluate the quality of life Change from baseline at 8 weeks and 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT02915848 - Long-term Stability of LFP Recorded From the STN and the Effects of DBS
Recruiting NCT03648905 - Clinical Laboratory Evaluation of Chronic Autonomic Failure
Terminated NCT02688465 - Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). Phase 4
Completed NCT05040048 - Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
Active, not recruiting NCT04006210 - Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations Phase 3
Completed NCT02562768 - A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease Phase 1
Completed NCT00105521 - Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia Phase 3
Completed NCT00105508 - Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia Phase 3
Recruiting NCT06002581 - Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease N/A
Completed NCT02236260 - Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation N/A
Completed NCT00529724 - Body Weight Gain, Parkinson, Subthalamic Stimulation Phase 2
Active, not recruiting NCT05699460 - Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
Completed NCT03703570 - A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations Phase 2
Completed NCT03462680 - GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures N/A
Completed NCT02837172 - Diagnosis of PD and PD Progression Using DWI
Not yet recruiting NCT04046276 - Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease N/A
Recruiting NCT02952391 - Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol N/A
Active, not recruiting NCT02937324 - The CloudUPDRS Smartphone Software in Parkinson's Study. N/A
Terminated NCT02894567 - Evaluation of Directional Recording and Stimulation Using spiderSTN N/A
Completed NCT02874274 - Vaccination Uptake (VAX) in PD N/A